Sarah Nemec
Vermögen: 5 448 $ am 30.06.2026
Vermögen: 5 448 $ am 30.06.2026
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.01.2026 | 1’415 ( 0.07% ) | 5 448 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Comptroller/Controller/Auditor | 15.05.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
BioElectron Technology Corp.
BioElectron Technology Corp. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic treatments for inherited mitochondrial diseases primarily affecting children | Corporate Officer/Principal | 01.10.2019 |
Blue Yonder Group, Inc.
Blue Yonder Group, Inc. Packaged SoftwareTechnology Services Develops AI driven supply chain platform | Corporate Officer/Principal | 01.01.2014 |
| AFFYMETRIX, INC. | Corporate Officer/Principal | 01.08.2010 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Blue Yonder Group, Inc.
Blue Yonder Group, Inc. Packaged SoftwareTechnology Services Develops AI driven supply chain platform | Technology Services |
Affymetrix, Inc.
Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
The Ohio University
The Ohio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
BioElectron Technology Corp.
BioElectron Technology Corp. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic treatments for inherited mitochondrial diseases primarily affecting children | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen